Related Experiment Video
Updated: Jul 5, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Transcriptional regulation of ASK/Dbf4 in cutaneous melanoma is dependent on E2F1
Sandeep Nambiar1, Alireza Mirmohammadsadegh, Mohamed Hassan
1Department of Dermatology, Heinrich-Heine-University, Duesseldorf, Germany.
Background:
Melanoma is a complex genetic disease, the management of which will require an in-depth understanding of the biology underlying its initiation and progression. Recently, we have reported the differential regulation of a novel gene, namely ASK/Dbf4, in melanoma and suggested upregulation of ASK/Dbf4 as a novel molecular determinant with prognostic relevance that confers a proliferative advantage in cutaneous melanoma. As trans-acting factor binding is fundamental to understand the regulation of gene expression, this study focuses on characterization of the specific transcriptional regulation of ASK/Dbf4 in melanoma.
Objective:
We investigated whether ASK/Dbf4 is a transcriptional target of the important cell cycle regulator E2F1 in melanoma.
Results:
As evidenced by gel supershift assays on nuclear extracts from various melanoma cell lines (SK-MEL-28, MV3, M13, A375 and BLM), E2F1 bound to the ASK/Dbf4 minimal promoter (MP). In addition, cisplatin-mediated abrogation of E2F1 binding to the ASK/Dbf4 MP resulted in a transcriptional decrease in ASK/Dbf4. Further, the current study also demonstrated that ASK/Dbf4 regulation was refractory to UVB, a well-known risk factor for melanoma.
Conclusions:
In summary, our study not only elucidated that ASK/Dbf4, a novel cell survival gene in melanoma was transcriptionally regulated by E2F1, but also that the induction of ASK/Dbf4 was refractory to UVB exposure suggesting that its upregulation was not an early event in melanomagenesis.
Insights
The cell cycle regulator E2F1 directly controls the expression of the novel melanoma gene ASK/Dbf4. This gene
Area of Science:
- Melanoma research
- Cancer genetics
- Molecular biology
Background:
- Melanoma is a complex genetic disease requiring a deep understanding of its underlying biology.
- The novel gene ASK/Dbf4 is differentially regulated in melanoma and confers a proliferative advantage.
- Understanding gene regulation is crucial for deciphering melanoma's progression.
Purpose of the Study:
- To investigate if ASK/Dbf4 is a transcriptional target of the cell cycle regulator E2F1 in melanoma.
- To characterize the specific transcriptional regulation of ASK/Dbf4 in melanoma.
Main Methods:
- Gel supershift assays on nuclear extracts from melanoma cell lines.
- Assessing the impact of E2F1 binding on ASK/Dbf4 transcription.
- Investigating ASK/Dbf4 regulation in response to UVB exposure.
Main Results:
- E2F1 was confirmed to bind to the ASK/Dbf4 minimal promoter in melanoma cells.
- Disruption of E2F1 binding led to a decrease in ASK/Dbf4 transcription.
- ASK/Dbf4 regulation was found to be unresponsive to UVB, a melanoma risk factor.
Conclusions:
- ASK/Dbf4, a novel cell survival gene in melanoma, is transcriptionally regulated by E2F1.
- The upregulation of ASK/Dbf4 is likely not an early event in melanomagenesis due to its refractoriness to UVB.
- This study provides critical insights into the molecular mechanisms driving melanoma progression.
Related Concept Videos
Master Transcription Regulators
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
MAPK Signaling Cascades
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply

